TG Therapeutics (TGTX) Stock Price, Quote, News & History | Benzinga

TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History

TGTXNASDAQ

Trade with Public

Trade with Public

$40.56

0.451.12%

At close: Jun 4, 5:00 PM EST

$40.45

-0.11-0.27%

After Hours: 7:12 PM EST

PRO

Why Is It Moving?™:TG Therapeutics shares are trading higher after the company announced that ...

OverviewNews Earnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$40.58

Close

$40.56

Volume / Avg.

2.34M / 2.05M

Day Range

$40.10 - $42.48

52 Wk Range

25.28 - 44.65

Market Cap

$6.19B

P/E Ratio

14.02

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

26.54%

Days to Cover

10.18

Recent TG Therapeutics Inc News

TG Therapeutics Stock Surges After Drug Trial Update

Shares of TG Therapeutics Inc (NASDAQ: TGTX) are climbing Wednesday after early-stage clinical trial data for new BRIUMVI MS formulation.

Henry Khederian

Why TG Therapeutics Stock Is Moving Today

TG Therapeutics shares are trading higher after the company reported preliminary fiscal-year 2025 total global revenue results

Dylan Berman

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, and the headline were updated in the story.) U.S. stock futures declined on Wednesday following Tuesday’s lower close. Futures of major benchmark indices declined.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-13.95M

Investing Cash Flow (TTM)

16.87M

Financing Cash Flow (TTM)

307.20M

Free Cash Flow (TTM)

-14.19M

Capital Expenditure (TTM)

-240.00K

Net Change in Cash (TTM)

310.12M

Analyst Trends and Forecast

1

Jan

1

Feb

2

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.97B

PE Ratio (TTM)

14.02

PE Ratio (FWD)

30.86

PEG Ratio (TTM)

-

PS Ratio (TTM)

9.20

PB Ratio (TTM)

10.53

Earnings Yield % (TTM)

7.13%

Earnings Yield % (FWD)

3.24%

EV / EBITDA (TTM)

42.47

Price / EBITDA (TTM)

42.92

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.81

Company Debt

Total Debt

$745.14M

LT Debt

$745.14M

LT Debt Issuance (TTM)

$747.66M

LT Debt Repayment (TTM)

-$255.00M

Total Cash

$442.21M

Debt to Equity

1.29

Issuance of Debt (TTM)

$492.66M

Repayment of Debt (TTM)

-$255.00M

Key Statistics

Open

$40.58

Close

$40.56

Volume / Avg.

2.34M / 2.05M

Day Range

$40.10 - $42.48

52 Wk Range

25.28 - 44.65

Market Cap

$6.19B

P/E Ratio

14.02

Dividend Yield

-

Exchange

NASDAQ

RSI

59

Short Interest

26.54%

Days to Cover

10.18

About

Sector

Health Care

Industry

Biotechnology

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, it has received approval fro...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy TG Therapeutics (TGTX) stock?

A

You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TG Therapeutics (TGTX) competitors?

A

There are no as such competitors for TG Therapeutics.

Q

What is the forecast, or price target, for TG Therapeutics (TGTX) stock?

A

TG Therapeutics has a consensus price target of $47.33.

Q

What is the current price for TG Therapeutics (TGTX)?

A

The stock price for TG Therapeutics (NASDAQ: TGTX) is $40.45 last updated June 4, 2026 at 7:12 PM EDT.

Q

Does TG Therapeutics (TGTX) pay a dividend?

A

There are no upcoming dividends for TG Therapeutics.

Q

When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?

A

TG Therapeutics does not have any upcoming earnings scheduled.

Q

Is TG Therapeutics (TGTX) going to split?

A

There is no upcoming split for TG Therapeutics.

Q

What sector and industry does TG Therapeutics (TGTX) operate in?

A

TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.